Literature DB >> 25537452

Effects of CHO-expressed recombinant lactoferrins on mouse dendritic cell presentation and function.

Shen-An Hwang1, Marian L Kruzel2, Jeffrey K Actor3.   

Abstract

Lactoferrin (LF), a natural iron-binding protein, has previously demonstrated effectiveness in enhancing the Bacillus Calmette-Guérin (BCG) tuberculosis vaccine. This report investigates immune modulatory effects of Chinese hamster ovary (CHO) cell-expressed recombinant mouse and human LFs on mouse bone marrow-derived dendritic cells (BMDCs), comparing homologous and heterologous functions. BCG-infected BMDCs were cultured with LF, and examined for class II presentation molecule expression. Culturing of BCG-infected BMDCs with either LF decreased the class II molecule-expressing population. Mouse LF significantly increased the production of IL-12p40, IL-1β and IL-10, while human LF-treated BMDCs increased only IL-1β and IL-10. Overlaying naïve CD4 T-cells onto BCG-infected BMDCs cultured with mouse LF increased IFN-γ, whereas the human LF-exposed group increased IFN-γ and IL-17 from CD4 T cells. Overlay of naïve CD8 T cells onto BCG-infected BMDCs treated with mouse LF increased the production of IFN-γ and IL-17, while similar experiments using human LF only increased IL-17. This report is the first to examine mouse and human recombinant LFs in parallel experiments to assess murine DC function. These results detail the efficacy of the human LF counterpart used in a heterologous system to understand LF-mediated events that confer BCG efficacy against Mycobacterium tuberculosis challenge.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  BCG; Lactoferrin; adjuvant; dendritic cells

Mesh:

Substances:

Year:  2014        PMID: 25537452      PMCID: PMC6005372          DOI: 10.1177/1753425914564609

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  62 in total

1.  Structure of the human lactoferrin gene and its chromosomal localization.

Authors:  S J Kim; D Y Yu; K W Pak; S Jeong; S W Kim; K K Lee
Journal:  Mol Cells       Date:  1998-12-31       Impact factor: 5.034

2.  Immunomodulatory effects of recombinant lactoferrin during MRSA infection.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Int Immunopharmacol       Date:  2014-03-06       Impact factor: 4.932

3.  Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression.

Authors:  Marian L Kruzel; Jeffrey K Actor; Michał Zimecki; Jasen Wise; Paulina Płoszaj; Shaper Mirza; Mark Kruzel; Shen-An Hwang; Xueqing Ba; Istvan Boldogh
Journal:  J Biotechnol       Date:  2013-09-23       Impact factor: 3.307

4.  Characterization of glycans in a lactoferrin isoform, lactoferrin-a.

Authors:  Z Wei; T Nishimura; S Yoshida
Journal:  J Dairy Sci       Date:  2001-12       Impact factor: 4.034

5.  Systemic or local co-administration of lactoferrin with sensitizing dose of antigen enhances delayed type hypersensitivity in mice.

Authors:  M Zimecki; M L Kruzel
Journal:  Immunol Lett       Date:  2000-11-01       Impact factor: 3.685

Review 6.  Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

Authors:  T Oettinger; M Jørgensen; A Ladefoged; K Hasløv; P Andersen
Journal:  Tuber Lung Dis       Date:  1999

7.  Recombinant human lactoferrin expressed in glycoengineered Pichia pastoris: effect of terminal N-acetylneuraminic acid on in vitro secondary humoral immune response.

Authors:  Byung-Kwon Choi; Jeffrey K Actor; Sandra Rios; Marc d'Anjou; Terrance A Stadheim; Shannon Warburton; Erin Giaccone; Michael Cukan; Huijuan Li; Angela Kull; Nathan Sharkey; Paul Gollnick; Maja Kocieba; Jolanta Artym; Michal Zimecki; Marian L Kruzel; Stefan Wildt
Journal:  Glycoconj J       Date:  2008-03-26       Impact factor: 2.916

8.  Comparison of bioactivities of talactoferrin and lactoferrins from human and bovine milk.

Authors:  Rulan Jiang; Xiaogu Du; Bo Lönnerdal
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-11       Impact factor: 2.839

9.  Failure of CD1D-/- mice to elicit hypersensitive granulomas to mycobacterial cord factor trehalose 6,6'-dimycolate.

Authors:  Tera V Guidry; Margaret Olsen; Ki-Soo Kil; Robert L Hunter; Yong-Jian Geng; Jeffrey K Actor
Journal:  J Interferon Cytokine Res       Date:  2004-06       Impact factor: 2.607

10.  Lactoferrin modulation of antigen-presenting-cell response to BCG infection.

Authors:  Katarzyna M Wilk; Shen-An Hwang; Jeffrey K Actor
Journal:  Postepy Hig Med Dosw (Online)       Date:  2007       Impact factor: 0.270

View more
  5 in total

1.  CHO expressed recombinant human lactoferrin as an adjuvant for BCG.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Int J Immunopathol Pharmacol       Date:  2015-08-27       Impact factor: 3.219

2.  Oral recombinant human or mouse lactoferrin reduces Mycobacterium tuberculosis TDM induced granulomatous lung pathology.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Biochem Cell Biol       Date:  2016-07-27       Impact factor: 3.626

3.  Recombinant human lactoferrin modulates human PBMC derived macrophage responses to BCG and LPS.

Authors:  Shen-An Hwang; Marian L Kruzel; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2016-09-28       Impact factor: 3.131

4.  Recombinant Human Lactoferrin Reduces Inflammation and Increases Fluoroquinolone Penetration to Primary Granulomas During Mycobacterial Infection of C57Bl/6 Mice.

Authors:  Thao K T Nguyen; Zainab Niaz; Marian L Kruzel; Jeffrey K Actor
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-02-28       Impact factor: 4.291

Review 5.  Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology.

Authors:  Jeffrey K Actor
Journal:  Mediators Inflamm       Date:  2015-12-14       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.